Nuvalent Inc’s recently made public that its Chief Scientific Officer Pelish Henry E. unloaded Company’s shares for reported $0.41 million on Aug 07 ’25. In the deal valued at $74.85 per share,5,500 shares were sold. As a result of this transaction, Pelish Henry E. now holds 60,956 shares worth roughly $4.57 million.
Then, Noci Darlene sold 4,000 shares, generating $321,440 in total proceeds. Upon selling the shares at $80.36, the Chief Development Officer now owns 48,034 shares.
Before that, BCLS II INVESTCO, LP bought 4,253 shares. Nuvalent Inc shares valued at $349,086 were divested by the Former Affiliate at a price of $82.08 per share.
UBS upgraded its Nuvalent Inc [NUVL] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late December with a ‘”a Buy”‘ rating. UBS began covering NUVL with “Neutral” recommendation on October 24, 2024. Barclays started covering the stock on August 29, 2024. It rated NUVL as “an Overweight”.
Price Performance Review of NUVL
On Monday, Nuvalent Inc [NASDAQ:NUVL] saw its stock jump 1.13% to $74.95. Over the last five days, the stock has lost -4.34%. Nuvalent Inc shares have risen nearly 11.14% since the year began. Nevertheless, the stocks have fallen -4.25% over the past one year. While a 52-week high of $113.51 was reached on 02/06/25, a 52-week low of $55.53 was recorded on 04/09/25.
Levels Of Support And Resistance For NUVL Stock
The 24-hour chart illustrates a support level at 73.04, which if violated will result in even more drops to 71.14. On the upside, there is a resistance level at 76.56. A further resistance level may holdings at 78.18.
How much short interest is there in Nuvalent Inc?
A steep rise in short interest was recorded in Nuvalent Inc stocks on 2025-07-15, growing by 0.29 million shares to a total of 5.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 5.21 million shares. There was a rise of 5.19%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 17, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $97 price target.
